Financials

MDxHealth® operates on a calendar basis with its accounting year ending on December 31.

The company reports its consolidated financial statements under International Financial Reporting Standards (IFRS) and all amounts are in US Dollars. MDxHealth publishes a consolidated and audited Annual Report on an annual basis, a consolidated Interim Report for its June 30 half-year financial figures, and business/financial updates at the end of Q1 and Q3.

Furthermore, for the Annual General Shareholders’ Meeting, the company also publishes the non-consolidated Belgian-GAAP financial statements of the parent company. Prior to October 5, 2010, MDxHealth operated under the name OncoMethylome Sciences

2020 Reporting Calendar

  • February 26: Publication of FY2019 results
  • April 9: Q1-2020 business update
  • April 28: Online publication of annual report 2019
  • May 28: Annual General Meeting
  • August 26: Publication of H1-2020 results
  • October 21: Q3-2020 business update

3-year Snapshot
In “000” of USD

Profit and Loss201920182017
Revenues11,78528,39740,508
Gross Profit3016,74530,305
Research and Development Expenses-8,897-4,280-3,505
General and Administrative Expenses-15,196-15,207(1)-39,142(2)
Selling and Marketing Expenses-17,809-29,591(1)
Other Operating (Expense)/Income-1,19723568
Operating Loss-43,169-32,098-12,274
Financial Expense, Net-506-393-127
Loss Before Income Tax-43,675-32,491-12,401
Income Tax57541113
Loss for the Year-43,100-32,450-12,288

(1) The comparative figures for 2018 have been reclassed to reflect the breakdown of Selling, General and Administrative Expenses into General and Administrative Expenses and Selling and Marketing Expenses.  (2) 2017 figures are the aggregate of Selling, General and Administrative Expenses.

Assests

201920182017
Total Non-Current Assets9,72117,61319,205
Total Current Assets30,90747,86339,316
Of Which Cash and Cash Equivalents22,05026,20316,827
Total Assets40,62865,47658,521

Liabilities and Shareholders’ Equity

201920182017
Total Equity19,72452,11743,546
Non-Current Liabilities10,4771,8821,860
Current Liabilities10,42711,47713,115
Total Liabilities40,62865,47658,521

Cash Flows

201920182017
Operating Cash Flow-22,289-28,543-10,450
Investing Cash Flow-73-1,345-5,965
Financing Cash Flow17,96541,672446
Cash and Cash Equivalents at End of Period22,05026,20316,827

Financial Reports

2019

2019 Interim Report: English | Français

2019 Consolidated Figures: English

2019 Board Report on Financial Statements: English I Français

2019 Full Non-consolidated Statutory Accounts: Français

2019 Annual Report: English I Français

2019 Auditor Opinion: English I Français

 

 

2018

2018 Interim Report: English | Français

2018 Consolidated Figures: English

2018 Board Report: English

2018 Full non consolidated statutory Accounts: Français

2018 Annual Report: English | Français

2018 Auditor Opinion: English | Français

2017

2017 Annual Report “after correction to take into account a clerical drafting error”: english | français

Full year 2017 Non Consolidated Statutory Account: français

Auditors Opinion: english | français

Board Report on 2017 Financial Statements “after correction to take into account a clerical drafting error”: english | français

2017 Consolidated figures: english

2017 Interim report: english | français

2016

2016 Annual Report: english | français

Full year 2016 Non Consolidated Statutory Account : français

Auditors Opinion: english

Board Report on 2016 Financial Statements: english | français

2016 Interim report : english | français

2016 Consolidated figures: english

2015

2015 Interim report : english | français

2015 Consolidated Statement of Comprehensive Income: english

2015 Annual Report : english | français

Full Year 2015 Non Consolidated Statutory Accounts: français

Auditors Opinion: english | français

2014

Full Annual Report: english | français

2014 Consolidated Statements: english

Full Year 2014 Non Consolidated Statutory Accounts: français

Auditors Opinion: english | français

2014 Interim Report: english | français

2013

2013 Interim Report: english | français

Full Annual Report: english | français

New full year 2013 non-consolidated statement account: français

Auditor’s opinion: english | français

Full year 2013 non-consolidated statutory accounts: français

Consolidated Financial Statements 2013: english

2012

Full year 2012 Registration Document (Annual Report): English | Français

2012 Auditor’s opinion: English | Français

Full year 2012 non-consolidated statutory accounts: Français

2012 Interim Report: English | Français

Consolidated Financial Statements 2012: English

2011

Full year 2011 Registration Document (Annual report): English | Français

2011 Auditor’s Opinion: English | Français

Full year 2011 non-consolidated statutory accounts and reports: Français

2011 Interim Report: English | Français

2011 Full Year Results Financial Report: English

2010

2010 Auditor’s Opinion: English | Français

Full year 2010 non-consolidated statutory accounts and reports: Français

2010 Full Year Results Financial Report: English

2010 Interim Report: English | Français

2009

Full year 2009 non-consolidated statutory accounts and reports: Français

2009 Full Year Results Financial Report: English

2009 Interim Report: English | Français

Full year 2009 Registration Document (Annual report): English | Français

2008

2008 Annual Brochure: English | Français

2008 Registration Document: English | Français

2008 Full Year Results Financial Report: English

2008 Interim Report: English | Français

2007

Full year 2007 Registration Document (Annual Report): English | Français

2007 Full Year Results: English | Français

2007 Full Year Results Financial Report: English

2007 Half Year Results: English | Français

2007 Half Year Results Financial Report: English

2006 Annual Brochure: English | Français

2006

Statutory Statements with Reports of Board and Auditor: English

2006 Half year Report (June 30 figures): Français

Full year 2006 Registration Document (Annual Report): English | Français

2006 Full Year Results: English | Français

2006 Full Year Results Financial Report: English

Investor Relations Contact

For all investor related questions please call or email:

LifeSci Advisor (PR &IR)

US: +1 646 597 6989
ir@mdxhealth.com